Nomic Flex

VO Health’s Molecular Fitness Blood Test™ will utilize deep protein profiling to estimate VO₂ Max and characterize the biological pathways underlying cardiorespiratory fitness and performance

Functional Proteomics of the PBMC Secretome

Detect toxicity before candidates advance. This application note shows how high-throughput proteomic profiling can reveal toxicity signals while helping resolve the mechanisms behind them.

Amanda McQuade and Nathaniel Robichaud discuss how integrated proteomic and transcriptomic profiling can reveal cellular responses to genetic perturbations that are not captured through RNA analysis alone.

Study will profile over 3,000 human liver-derived samples to generate proteomic training datasets for New Approach Methodologies and AI-enabled toxicity prediction

High-plex protein profiling across 1,500+ perturbed PBMC samples enables functional mapping of immune genetics across diverse Latin American cohorts

Nomic and Broad Clinical Labs partner to unlock broader applications for proteomics through high-plex, quantitative data that enables cross-study comparable insights.

Discover how scalable, quantitative proteomics bridges drug development from discovery screens to clinical translation

Proteomics has long required compromise: breadth versus cost, absolute quantification versus depth, scalability versus insight. Omni 1000 eliminates those constraints, delivering 1063 rigorously selected proteins in a single quantitative assay, yielding data that is interoperable across studies.

Hosted by Nathaniel Robichaud, PhD, Partnerships Lead at Nomic, this video explores findings from our large-scale PBMC screen and their implications for multiple sclerosis.

The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a 1.4 million–protein PBMC dataset available in the Nomic Portal.

In this webinar Lloyd Bod, PhD and Nathaniel Robichaud, PhD, will discuss how large-scale profiling of the circulating proteome across multiple cancer types reveals unique tumor-specific protein signatures and provides new insights into treatment response.

Nomic’s nELISA® technology is a versatile, proteome-wide multiplexed solution designed for scalable, high-throughput protein quantification. At its core is a library of 1,000 expertly curated assays developed to support drug development and biomarker discovery.

Proteomics without Compromise

For the first time, researchers can access a quantitative proteome-wide solution that profiles 1000 of the most informative proteins at high-throughput.

1000 Proteins to Unlock the Proteome: Delivering Affordable, Scalable, and Quantitative Proteomics.

How nELISA miniaturizes immunoassays on beads, overcoming reagent-driven cross-reactivity and reducing costs.

BioRxiv ; We present the nELISA, a miniaturised, high-throughput, and high-fidelity protein profiling platform.

True Multiplexing Unlocks Scalable Proteomics

High-throughput protein profiling technology enables comprehensive and quantitative mapping of cytokine interactions

Project will quantify circulating protein markers in ~3000 patient blood samples from PICI’s RADIOHEAD study using Nomic’s nELISA™ high-throughput protein profiling platform to better understand how patients respond to treatment

Nomic is closing of an oversubscribed US$17 million Series A funding round, bringing the company's total funding to date to over US$21 million.

Hewett brings invaluable operational and strategic expertise to guide Nomic Bio through its crucial years of growth.

Nomic’s nELISA will be used to profile 200 secreted proteins for ten thousand samples to provide consortium partners complementary information about the secretome

Accessing our profiling service is a simple and seamless experience. We offer comprehensive, end-to-end support to help you harness the power of the proteome.

The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.

Enabling well-powered studies, absolute quantification, and unlimited content flexibility